Who’s at BRIQ

CSIRO’s research teams based at the Ecosciences Precinct specialise in environmental science, climate adaptation and sustainable resource management. As Australia’s national science agency, with over 5000 patents and 150 spin-off companies, CSIRO develops breakthrough solutions in areas including biodiversity conservation, water management and agricultural resilience.

Delivering cutting-edge environmental science shaping policy and protecting natural heritage. Through its Chemistry Centre and research teams, the department provides critical monitoring and analytical services supporting Great Barrier Reef protection and sustainable resource management.

Leading pioneering research across Queensland’s farming, fisheries and forestry sectors. Its scientists develop breakthrough solutions in crop science, animal health and biosecurity. Through industry collaboration, DPI strengthens Queensland’s primary industries while enhancing their sustainability.

Coordinating Queensland’s infrastructure strategy and economic development. This includes securing major projects, facilitating private sector investment, and streamlining planning frameworks to support industry growth and job creation.

Griffith University provides world-leading expertise in drug discovery, clinical trials and pharmaceutical sciences. Ranked in the top 2% of universities worldwide and home to the Centre for Drug Discovery and Development, Griffith advances therapeutic breakthroughs through partnerships with industry, clinicians and research communities.

Metro South Hospital and Health Service oversees Brisbane’s southern suburbs’ healthcare, including the Princess Alexandra Hospital (PAH)—Australia’s first large-scale digital public hospital. As a premier healthcare and research hub, PAH advances medical innovation through strategic partnerships with academia and industry.

Queensland Health delivers accessible, high-quality healthcare across the state through a network of 16 hospitals and health services serving over 5 million Queenslanders. Through its partnership with TRI, Queensland Health transforms research into clinical solutions that improve health outcomes nationally.

QIC is a leading Australian investment manager with expertise in mixed-use urban developments. Managing over $100bn in assets, QIC creates sustainable town centres and workplaces where life and enterprise intersect seamlessly, supporting the growth of knowledge-intensive precincts.

Ranked among Australia’s top universities for commercialisation success, QUT specialises in translating research into market-ready health innovations. Through its integration with TRI, QUT combines next-generation talent development with translational research, building on Australia’s highest rated biomedical engineering research and over 100 active industry collaborations.

Operating in Australia since 1980, Sanofi is a global biopharmaceutical leader advancing healthcare through innovative medicines and vaccines. At TRI, the Sanofi team addresses immunology, oncology, rare diseases and diabetes while supporting public health through vaccine development and biomanufacturing. The company’s significant investment in mRNA technology and research facilities at TRI positions Brisbane as a key node in global vaccine development.

Ranked in Australia’s top three universities and among the world’s top 50, the University of Queensland is a cornerstone partner in the Translational Research Institute. Home to Australia’s largest medical research endowment and world-class expertise in pharmaceutical sciences, UQ’s School of Pharmacy and TRI Ian Frazer Institute pioneer breakthrough immunotherapy and medical advancements for children.

Thermo Fisher Scientific is a global leader in scientific solutions serving healthcare, life sciences and biotechnology. Its offerings span laboratory equipment, diagnostics and pharmaceutical manufacturing. At TRI, Thermo Fisher advances vaccine development and biomedical research, addressing local and global health challenges.

TRI is Australia’s first initiative dedicated to accelerating medical progress from laboratory to patient care. The state-of-the-art facility brings together Queensland University, Queensland University of Technology, Metro South Health, Mater Research and others to tackle health challenges, fast-tracking breakthroughs in medical research. Tenants of TRI include 360biolabs, AvanCell, Brandon Capital, EMVision, HTQ, Infensa Bioscience, LSQ, Microba Life Sciences, Microbio, Ocugene, Oroborus, TIA and UniQuest.